Markets
IDYA

IDEAYA Appoints Joshua Bleharski As CFO

February 10, 2025 — 06:29 am EST

Written by RTTNews.com for RTTNews->

(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, Monday announced the appointment of Joshua Bleharski as chief financial officer.

Before joining IDEAYA, Bleharski was Managing Director and Global Co-Head of Biopharma at J.P. Morgan's Healthcare Investment Banking group for 17 years. IDEAYA expects Bleharski to fully transition into his new role by early May.

In the pre-market trading, IDEAYA Biosciences is 1.83% lesser at $22.58 on the Nasdaq.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

IDYA

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.